Susquehanna International Group
GNVC

Susquehanna International Group’s GenVec, Inc. GNVC Stock Holding History

Susquehanna International Group’s Portfolio GNVC Stock Details GNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-2,196
Closed -$8K – 9297
2013
Q2 		$8K Buy
+2,196
New +$18.5K ﹤0.01% 8099

Other funds holding GNVC

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Susquehanna International Group's GNVC Position: Q3 2013 in Review

Susquehanna International Group sold out of GenVec, Inc. (GNVC) in Q3 2013, closing a stake of 2,196 shares — an estimated $8K sold.

Susquehanna International Group first reported a position in GNVC in Q2 2013 and held it in 1 quarter. The position peaked at $8K in Q2 2013. 16 funds tracked by Wall St. Rank hold GNVC as of Q3 2013.

  • Susquehanna International Group reported no remaining GenVec, Inc. position as of Q3 2013 after selling out during the quarter.
  • Susquehanna International Group sold 2,196 GenVec, Inc. shares in Q3 2013, an estimated $8K.
  • Susquehanna International Group first reported a position in GenVec, Inc. in Q2 2013 and held it in 1 quarter.
  • Susquehanna International Group's GenVec, Inc. position peaked at $8K in Q2 2013.
  • 16 funds tracked by Wall St. Rank held GenVec, Inc. as of Q3 2013.

Based on Susquehanna International Group's 13F filing for Q3 2013, filed 13 Nov 2013.